CVD Prevention and Control is relaunched as Global Heart

2011 ◽  
Vol 6 (3) ◽  
pp. 121
2018 ◽  
Vol 8 (1) ◽  
pp. 1-9
Author(s):  
Senka Mesihovic-Dinarevic ◽  
Aida Ramić-Čatak ◽  
Zaim Jatic

Cardiovascular diseases (CVDs) are the major cause of disability and premature death all over the world. Annually, 17.5 million people die from CVDs, representing 30% of the total number of deaths. Despite established guidelines for the treatment of acute coronary syndrome, cardiac weakness, atrial fibrillation and CVD prevention, many patients remain inadequately treated, particularly in less developed nations. A brief overview of the development of CVDs, description of the current practice guidelines, and a cross sectional analyses of the status of CVD prevention and control in the Federation of Bosnia and Herzegovina is given. In the past 7 years, there has been a steady increase in deaths, where half of all deaths in the Federation of Bosnia and Herzegovina are attributed to CVDs. Deaths from the acute myocardial infarction had a rate of 91.0/100,000 inhabitants, a significant increase compared to 2010, when this rate was 69.2. The second leading cause of death, a stroke, with a rate of 87.1 showed a slight decrease compared to 2010, when it was 89.9. The third leading cause of death, heart failure, with a rate of 68.4, has a slight decrease compared to 2010, when the rate was 75.7. CVDs are the leading cause of mortality in Federation of Bosnia and Herzegovina, which, in addition to the large number of premature deaths, also causes major costs for the health sector and economy.


Author(s):  
Seng Chuen Tan ◽  
Liming Li ◽  
Wei Yu ◽  
Can Chen ◽  
Ruizhi Shi

<p style="margin: 0cm 9.35pt 0pt 0cm; text-align: justify; -ms-text-justify: inter-ideograph;"><span style="line-height: 200%; font-family: 'Times New Roman','serif'; font-size: 12pt;" lang="EN-GB">Major cardiovascular risk factors in China</span><span style="line-height: 200%; font-family: 'Times New Roman','serif'; font-size: 12pt; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-fareast-language: ZH-CN;" lang="EN-GB">, such as hyperlipidemia, hypertension, dietary factors, exposure to tobacco, diabetes, obesity and physical inactivity, </span><span style="line-height: 200%; font-family: 'Times New Roman','serif'; font-size: 12pt;" lang="EN-GB">have contributed to deteriorating trends in cardiovascular disease (CVD) deaths. In past years, a number of CVD prevention programs have been initiated in European and American countries and successfully brought down CVD related death rate by involving various parties such as physicians, patients, government agencies and payers. However, there is </span><span style="line-height: 200%; font-family: 'Times New Roman','serif'; font-size: 12pt; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-fareast-language: ZH-CN;" lang="EN-GB">rare</span><span style="line-height: 200%; font-family: 'Times New Roman','serif'; font-size: 12pt;" lang="EN-GB"> published literature that systemically reviewed such experience, which would be highly valuable for China and other countries with high CVD burden. In this article, we review the published literature on CVD prevention and control programs and report on interviews of local and foreign experts to provide recommendations for China-specific CVD prevention </span><span style="line-height: 200%; font-family: 'Times New Roman','serif'; font-size: 12pt; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-fareast-language: ZH-CN;" lang="EN-GB">and control </span><span style="line-height: 200%; font-family: 'Times New Roman','serif'; font-size: 12pt;" lang="EN-GB">programs. </span><span style="line-height: 200%; font-family: 'Times New Roman','serif'; font-size: 12pt; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-fareast-language: ZH-CN;" lang="EN-GB">In order to provide practical suggestions, w</span><span style="line-height: 200%; font-family: 'Times New Roman','serif'; font-size: 12pt;" lang="EN-GB">e describe the type of programs as patient, physician, pharmacist, nurse, or payer-focused. Based on this evidence and identified challenges in China, programs focusing on disease management, treatment adherence, physician/health care provider education, financial incentives, and integrated healthcare are recommended for the prevention and control of CVD in China.</span></p>


2005 ◽  
Vol 24 (4, Suppl) ◽  
pp. S106-S110 ◽  
Author(s):  
Kevin D. McCaul ◽  
Ellen Peters ◽  
Wendy Nelson ◽  
Michael Stefanek

Sign in / Sign up

Export Citation Format

Share Document